Literature DB >> 32266384

Adrenal Incidentaloma.

Mark Sherlock1,2, Andrew Scarsbrook3, Afroze Abbas4, Sheila Fraser5, Padiporn Limumpornpetch6, Rosemary Dineen1,2, Paul M Stewart6.   

Abstract

An adrenal incidentaloma is now established as a common endocrine diagnosis that requires a multidisciplinary approach for effective management. The majority of patients can be reassured and discharged, but a personalized approach based upon image analysis, endocrine workup, and clinical symptoms and signs are required in every case. Adrenocortical carcinoma remains a real concern but is restricted to <2% of all cases. Functional adrenal incidentaloma lesions are commoner (but still probably <10% of total) and the greatest challenge remains the diagnosis and optimum management of autonomous cortisol secretion. Modern-day surgery has improved outcomes and novel radiological and urinary biomarkers will improve early detection and patient stratification in future years to come. © Endocrine Society 2020.

Entities:  

Keywords:  adrenal adenoma; adrenal computed tomography; adrenal cortical carcinoma; adrenal incidentaloma; autonomous cortisol secretion

Mesh:

Year:  2020        PMID: 32266384      PMCID: PMC7431180          DOI: 10.1210/endrev/bnaa008

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  372 in total

Review 1.  Adrenal imaging: a comprehensive review.

Authors:  Myles Taffel; Shawn Haji-Momenian; Paul Nikolaidis; Frank H Miller
Journal:  Radiol Clin North Am       Date:  2012-03       Impact factor: 2.303

2.  Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.

Authors:  Yusuke Sato; Shigekatsu Maekawa; Ryohei Ishii; Masashi Sanada; Teppei Morikawa; Yuichi Shiraishi; Kenichi Yoshida; Yasunobu Nagata; Aiko Sato-Otsubo; Tetsuichi Yoshizato; Hiromichi Suzuki; Yusuke Shiozawa; Keisuke Kataoka; Ayana Kon; Kosuke Aoki; Kenichi Chiba; Hiroko Tanaka; Haruki Kume; Satoru Miyano; Masashi Fukayama; Osamu Nureki; Yukio Homma; Seishi Ogawa
Journal:  Science       Date:  2014-05-23       Impact factor: 47.728

3.  18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.

Authors:  M Yun; W Kim; N Alnafisi; L Lacorte; S Jang; A Alavi
Journal:  J Nucl Med       Date:  2001-12       Impact factor: 10.057

4.  Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Authors:  Siyuan Zheng; Andrew D Cherniack; Ninad Dewal; Richard A Moffitt; Ludmila Danilova; Bradley A Murray; Antonio M Lerario; Tobias Else; Theo A Knijnenburg; Giovanni Ciriello; Seungchan Kim; Guillaume Assie; Olena Morozova; Rehan Akbani; Juliann Shih; Katherine A Hoadley; Toni K Choueiri; Jens Waldmann; Ozgur Mete; A Gordon Robertson; Hsin-Ta Wu; Benjamin J Raphael; Lina Shao; Matthew Meyerson; Michael J Demeure; Felix Beuschlein; Anthony J Gill; Stan B Sidhu; Madson Q Almeida; Maria C B V Fragoso; Leslie M Cope; Electron Kebebew; Mouhammed A Habra; Timothy G Whitsett; Kimberly J Bussey; William E Rainey; Sylvia L Asa; Jérôme Bertherat; Martin Fassnacht; David A Wheeler; Gary D Hammer; Thomas J Giordano; Roel G W Verhaak
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

5.  A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.

Authors:  Anelia Horvath; Sosipatros Boikos; Christoforos Giatzakis; Audrey Robinson-White; Lionel Groussin; Kurt J Griffin; Erica Stein; Elizabeth Levine; Georgia Delimpasi; Hui Pin Hsiao; Meg Keil; Sarah Heyerdahl; Ludmila Matyakhina; Rossella Libè; Amato Fratticci; Lawrence S Kirschner; Kevin Cramer; Rolf C Gaillard; Xavier Bertagna; J Aidan Carney; Jérôme Bertherat; Ioannis Bossis; Constantine A Stratakis
Journal:  Nat Genet       Date:  2006-06-11       Impact factor: 38.330

Review 6.  Genetic testing for pheochromocytoma-associated syndromes.

Authors:  Chr Pawlu; B Bausch; N Reisch; H P H Neumann
Journal:  Ann Endocrinol (Paris)       Date:  2005-06       Impact factor: 2.478

7.  Adrenal incidentaloma: clinical characteristics and comparison between patients with and without extraadrenal malignancy.

Authors:  G Tsvetov; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

8.  Adrenal incidentalomas: experience in a developing country.

Authors:  P R K Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 9.  MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas.

Authors:  Isabelle Bourdeau; Nada El Ghorayeb; Nadia Gagnon; André Lacroix
Journal:  Eur J Endocrinol       Date:  2018-05-10       Impact factor: 6.664

10.  Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.

Authors:  M Conall Dennedy; Anand K Annamalai; Olivia Prankerd-Smith; Natalie Freeman; Kuhan Vengopal; Johann Graggaber; Olympia Koulouri; Andrew S Powlson; Ashley Shaw; David J Halsall; Mark Gurnell
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

View more
  30 in total

1.  Concomitant Existence of Bilateral Adrenal Adenomas. To Operate or Not?

Authors:  Christos Damaskos; Nikolaos Garmpis; Dimitrios Dimitroulis; Anna Garmpi; Paraskevi Farmaki; Alexandros Patsouras; Vasilili Epameinondas Georgakopoulou; Georgios Kyriakos; Lourdes Victoria Quiles-Sanchez; Athanasios Syllaios; Aliki Liakea; Evangelos Diamantis
Journal:  Maedica (Bucur)       Date:  2021-12

2.  Subclinical Hypercortisolism: An Important, Unrecognized Dysfunction.

Authors:  Lara Pizzorno; Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2022-07

3.  Adrenal Incidentaloma Needs thorough Biochemical Evaluation - An Institutional Experience.

Authors:  Akash N Shah; Uma K Saikia; Bipul K Chaudhary; Ashok K Bhuyan
Journal:  Indian J Endocrinol Metab       Date:  2022-04-27

4.  Predictive Factors of Functioning Adrenal Incidentaloma: A 15-Year Retrospective Study.

Authors:  Natwara Muangnoo; Worapaka Manosroi; Napitch Leelathanapipat; Tanaporn Meejun; Pattanan Chowchaiyaporn; Pasinee Teetipsatit
Journal:  Medicina (Kaunas)       Date:  2022-04-27       Impact factor: 2.948

5.  Congenital adrenal hyperplasia in patients with adrenal tumors: a population-based case-control study.

Authors:  F Sahlander; J Patrova; B Mannheimer; J D Lindh; H Falhammar
Journal:  J Endocrinol Invest       Date:  2022-10-21       Impact factor: 5.467

6.  Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.

Authors:  Roberto Olmos; Nicolás Mertens; Anand Vaidya; Thomas Uslar; Paula Fernandez; Francisco J Guarda; Álvaro Zúñiga; Ignacio San Francisco; Alvaro Huete; René Baudrand
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

7.  Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Authors:  Mircea-Florin Costache; Raluca-Elena Arhirii; Simona-Juliette Mogos; Corina Lupascu-Ursulescu; Cezara-Ioana Litcanu; Adi-Ionut Ciumanghel; Catalina Cucu; Cristina-Mihaela Ghiciuc; Antoniu-Octavian Petris; Nicolae Danila
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 8.  Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Authors:  Alfred King-Yin Lam
Journal:  Biomedicines       Date:  2021-02-10

Review 9.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

10.  An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy.

Authors:  Arvind Maheshwari; Todd Nippoldt; Caroline Davidge-Pitts
Journal:  J Endocr Soc       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.